The Democratic Republic of Congo has given the green light to an experimental vaccine to combat an ongoing Ebola outbreak. While the vaccine is not licensed, it has shown promising signs in a clinical trial.
The Democratic Republic of Congo approved the use of an experimental Ebola vaccine on Monday to combat the ongoing outbreak in the country.
"The non-objection was given. Now there's a Medecins Sans Frontiers (Doctors Without Borders) team that is arriving (in Congo) today to validate the protocol with the technical teams," Health Ministry spokesman Jonathan Simba told Reuters by telephone.
While there is no licensed vaccine to fight the Ebola virus, the World Health Organization (WHO) said the Ebola vaccine in question had performed well in a clinical trial in Guinea. The 5,837 subjects who used the experimental vaccine, known as rVSV-ZEBOV, were not infected with the virus 10 days after vaccination, as compared with 23 cases of Ebola in the 6,004 subjects who were not vaccinated.